Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Bladder Cancer

Free Subscription 11.05.2026 1 Actas Urol Esp (Engl Ed) 1 Biochim Biophys Acta Mol Basis Dis 1 Bioinform Adv 1 Biosci Rep 1 BJU Int 1 BJUI Compass 1 BMC Urol 1 BMJ Open 2 Can J Urol 1 Cancer Lett 1 Cell Death Discov 2 Cell Mol Bioeng 1 Cell Signal 1 Clin Genitourin Cancer 1 Comput Biol Chem 1 Crit Rev Oncol Hematol 1 Cytotechnology 1 Eur J Pharmacol 1 Eur Urol 3 Front Immunol 3 Front Oncol 1 Hereditas 1 Indian J Urol 1 Int Immunopharmacol 1 Int J Biol Sci 6 Int J Mol Sci 3 Int J Urol 1 Interdiscip Cardiovasc Thorac Surg 1 J Am Chem Soc 1 J Clin Invest 1 J Clin Med 1 J Extracell Biol 1 J Forensic Sci 1 Mater Today Bio 1 Medicina (Kaunas) 1 Medicine (Baltimore) 1 Mol Oncol 1 Nano Lett 1 Oncol Lett 1 Pathol Res Pract 1 Pharmaceuticals (Basel) 1 Pharmacol Res Perspect 1 Photodiagnosis Photodyn Ther 2 PLoS One 1 Rev Med Inst Mex Seguro Soc 1 Sci Rep 1 Support Care Cancer 1 Surg Pathol Clin 1 Ulus Travma Acil Cerrahi Derg 1 Urol Oncol 1 Urol Res Pract 1 Vet Surg 1 World J Urol 1 Zhonghua Zhong Liu Za Zhi

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Actas Urol Esp (Engl Ed)

1. ERGIN IE, Sanci A, Hepsen E, Sarikaya K, et al
   Predictive factors for urethral stricture development in patients with bladder tumor: The role of intravesical BCG therapy.
   Actas Urol Esp (Engl Ed). 2026;50:501908.
   PubMed         Abstract available
   
   

   
   Biochim Biophys Acta Mol Basis Dis

2. LIANG Z, Wang L, Li D, Chen Y, et al
   Targeted inhibition of the H3K27ac/OGT/O-GlcNAcylation axis to overcome gemcitabine-induced chemotherapy resistance in bladder cancer.
   Biochim Biophys Acta Mol Basis Dis. 2026 Apr 30:168281.
   PubMed         Abstract available
   
   

   
   Bioinform Adv

3. NAFI MMI, Md Rahat Hossain K
   DeepBCTPred: deep learning-based prediction of bladder cancer tissues from endoscopic images.
   Bioinform Adv. 2026;6:vbag087.
   PubMed         Abstract available
   
   

   
   Biosci Rep

4. LIANG H, Huang H, Li Y, Lu Y, et al
   Retraction: CircRNA_0058063 functions as a ceRNA in bladder cancer progression via targeting miR-486-3p/FOXP4 axis.
   Biosci Rep. 2026;46:BSR20193484.
   PubMed        
   
   

   
   BJU Int

5. CHETHAN GS, Patil NS
   Comment on 'Long-term multicentre analysis of robot-assisted radical cystectomy for non-muscle-invasive bladder cancer'.
   BJU Int. 2026 May 7. doi: 10.1111/bju.70313.
   PubMed        
   
   

   
   BJUI Compass

6. ISHIZUYA Y, Kawashima A, Yamashita S, Ujike T, et al
   Preoperative FAN score predicts survival outcomes after radical cystectomy for bladder cancer.
   BJUI Compass. 2026;7:e70221.
   PubMed         Abstract available
   
   

   
   BMC Urol

7. AGHAYEV A, Durak HM, Hepsen E, Dinc E, et al
   Clinical value of VI-RADS score in predicting repeat transurethral resection in primary bladder cancer: a prospective observational study.
   BMC Urol. 2026 May 1. doi: 10.1186/s12894-026-02131.
   PubMed         Abstract available
   
   

   
   BMJ Open

8. LEINUM LR, Jensen BT, Lauridsen SV
   Factors influencing adherence to intravesical instillation therapies for non-muscle-invasive bladder cancer: a scoping review protocol.
   BMJ Open. 2026;16:e116776.
   PubMed         Abstract available
   
   

   
   Can J Urol

9. ZHANG W, Peng X
   Genetic evidence against a causal relationship between myocardial infarction and urological malignancies.
   Can J Urol. 2026;33:387-401.
   PubMed         Abstract available
   
   
10. LIATSOS G, Zioutou K, Avramidis K, Vamvakaris K, et al
    Bladder cancer patients hospitalized in a medicine ward including three fuo cases following bacillus calmette-guerin immunotherapy.
    Can J Urol. 2026;33:349-360.
    PubMed         Abstract available
    
    

    
    Cancer Lett

11. AMARA CS, Piyarathna DWB, Kamal AHM, Chan YS, et al
    Cigarette smoke induces FASN-dependent fatty acid metabolic rewiring to drive bladder cancer progression.
    Cancer Lett. 2026 May 4:218562. doi: 10.1016/j.canlet.2026.218562.
    PubMed         Abstract available
    
    

    
    Cell Death Discov

12. HUANG R, Yu J, Bai R, Jiang W, et al
    FBXL6 promotes bladder cancer progression by stabilizing ENO1 through K63-linked ubiquitination.
    Cell Death Discov. 2026 May 6. doi: 10.1038/s41420-026-03130.
    PubMed         Abstract available
    
    

    
    Cell Mol Bioeng

13. CARIGNAN L, Alavi R, Millet M, Lavigne M, et al
    Erratum: Publisher Correction: Assessing the Relationship Between Bladder Cancer Cell Contractile Phenotypes and Their Invasive Properties.
    Cell Mol Bioeng. 2026;19:223.
    PubMed         Abstract available
    
    
14. CARIGNAN L, Alavi R, Millet M, Lavigne M, et al
    Assessing the Relationship Between Bladder Cancer cell Contractile Phenotypes and their Invasive Properties.
    Cell Mol Bioeng. 2026;19:207-221.
    PubMed         Abstract available
    
    

    
    Cell Signal

15. ZHANG Y, Zhao K, Du W, Hu L, et al
    LC3B promotes bladder cancer cell proliferation via the Sp1-cyclin D1/p27 axis with pan-cancer clinical associations.
    Cell Signal. 2026;145:112560.
    PubMed         Abstract available
    
    

    
    Clin Genitourin Cancer

16. SHIMODA M, Ito H, Aoki T, Karibe J, et al
    Comparative Analysis of Risk Stratifications for Non-Muscle-Invasive Bladder Cancer According to the Classifications Provided by the National Comprehensive Cancer Network, European Association of Urology, and Japanese Urological Association Guidelines
    Clin Genitourin Cancer. 2026;24:102560.
    PubMed         Abstract available
    
    

    
    Comput Biol Chem

17. QIN R, Li C, Zhang T, Wang Y, et al
    Identification of naringenin chalcone as a key gut metabolite for bladder cancer intervention: An integrated strategy combining network pharmacology and molecular dynamics simulation.
    Comput Biol Chem. 2026;124.
    PubMed         Abstract available
    
    

    
    Crit Rev Oncol Hematol

18. ZHANG T, Gao Z, Xiao S, Zou X, et al
    Precision Medicine in Bladder Cancer: Redefining Treatment Paradigms Through ADCs, Immunotherapy, and Molecular Subtyping.
    Crit Rev Oncol Hematol. 2026 May 1:105348. doi: 10.1016/j.critrevonc.2026.105348
    PubMed         Abstract available
    
    

    
    Cytotechnology

19. WU N, He X
    FTO promotes bladder cancer progression and stemness-associated phenotypes.
    Cytotechnology. 2026;78:103.
    PubMed         Abstract available
    
    

    
    Eur J Pharmacol

20. WANG J, He K, Qi H, Xu J, et al
    Icariside II suppresses bladder cancer progression via endoplasmic reticulum stress-mediated autophagy and lysosomal dysfunction.
    Eur J Pharmacol. 2026;1025:178924.
    PubMed         Abstract available
    
    

    
    Eur Urol

21. ROVIELLO G, Antonuzzo L
    Re: Perioperative enfortumab vedotin and pembrolizumab in bladder cancer.
    Eur Urol. 2026 Apr 30:S0302-2838(26)02145-7. doi: 10.1016/j.eururo.2026.
    PubMed        
    
    

    
    Front Immunol

22. LUO G, Wang W, Tai S, Yan L, et al
    Ribosome biogenesis programs define a three-gene RBscore with prognostic relevance in bladder cancer.
    Front Immunol. 2026;17:1810132.
    PubMed         Abstract available
    
    
23. CHENG Y, Deng W, Liu Y, Chen G, et al
    Research progress in augmentation strategies for PD-1/PD-L1 inhibitors in bladder cancer: from biological determinants to clinical applications.
    Front Immunol. 2026;17:1802404.
    PubMed         Abstract available
    
    
24. SHEN J, Wang C, Li T, Guan H, et al
    Identification of a migrasome-related lncRNA signature and its prognostic and immunological role in bladder cancer.
    Front Immunol. 2026;17:1763443.
    PubMed         Abstract available
    
    

    
    Front Oncol

25. MANTICA G, Esperto F, Malinaric R
    Editorial: Microbial biomarkers predicting BCG therapy response in non-muscle invasive bladder cancer.
    Front Oncol. 2026;16:1831100.
    PubMed        
    
    
26. PAN M, Tao T, Kong D, Gong H, et al
    Aerobic glycolysis in bladder cancer: research advances and targeted therapy potential.
    Front Oncol. 2026;16:1799955.
    PubMed         Abstract available
    
    
27. ZIMAK Z, Vidovic D, Kulis T, Hauptman D, et al
    High feasibility and safety of office-based transurethral laser ablation for recurrent non-muscle invasive bladder cancer: a single-center experience.
    Front Oncol. 2026;16:1683009.
    PubMed         Abstract available
    
    

    
    Hereditas

28. WU P, Chen L, Yang J, Liang Z, et al
    STEAP2-associated modulation of PI3K/AKT/mTOR signaling contributes to ginkgetin-induced apoptosis in bladder cancer cells.
    Hereditas. 2026 May 1. doi: 10.1186/s41065-026-00686.
    PubMed         Abstract available
    
    

    
    Indian J Urol

29. AGRAWAL S
    A new standard for cisplatin-ineligible muscle-invasive bladder cancer: Landmark results from KEYNOTE-905.
    Indian J Urol. 2026;42:172-173.
    PubMed        
    
    

    
    Int Immunopharmacol

30. ZHOU Y, Huang Y, Jian N, Zhu Y, et al
    MFAP4 activates PI3K/AKT-NF-kappaB signaling to drive tumor progression and immune evasion in bladder cancer.
    Int Immunopharmacol. 2026;182:116719.
    PubMed         Abstract available
    
    

    
    Int J Biol Sci

31. CHENG C, Gao J, Wang R, Wu Y, et al
    NOP2-mediated 5-methylcytosine Regulates Lipid Metabolism Reprogramming to Prime Tumors for Ferroptosis in Bladder Cancer Progression.
    Int J Biol Sci. 2026;22:4399-4416.
    PubMed         Abstract available
    
    

    
    Int J Mol Sci

32. DURMANOVA V, Mikolaskova I, Javor J, Ocenasova A, et al
    Association of IL6 rs1800795, TNF rs1800629, CCL2 rs1024611 and VEGFA rs699947 Polymorphisms with Bladder Cancer Risk, Tumor Aggressiveness, and HRV Parameters of Autonomic Nervous System Regulation.
    Int J Mol Sci. 2026;27:3361.
    PubMed         Abstract available
    
    
33. GRAPSA D, Sassi M, Mikou P
    Performance of Urine Fluorescence In Situ Hybridization for Diagnosis of Upper Tract Urothelial Carcinoma: A Comprehensive Review.
    Int J Mol Sci. 2026;27:3406.
    PubMed         Abstract available
    
    
34. CAO Y, Ma J, Tang X, Cui Y, et al
    HCN2 Promotes BGN Transcription via REST to Regulate Ferroptosis and Tumor Progression in Bladder Cancer.
    Int J Mol Sci. 2026;27:3433.
    PubMed         Abstract available
    
    
35. KWON WA, Lee YJ, Song YS
    Dynamic Precision Oncology for Real-Time Molecular Monitoring and Management in Urothelial Carcinoma.
    Int J Mol Sci. 2026;27:3474.
    PubMed         Abstract available
    
    
36. PACZEK S, Olkowicz M, Kudelski J, Gudowska-Sawczuk M, et al
    The Role of Gasdermin B-Mediated Pyroptosis in Bladder Cancer Diagnosis.
    Int J Mol Sci. 2026;27:3540.
    PubMed         Abstract available
    
    
37. BALTACIOGLU A, Acar O, Sonmez C, Saglican Y, et al
    Serum Trimethylamine-N-Oxide and Its Precursors as a Diagnostic Biomarker Panel for Non-Muscle-Invasive Bladder Cancer.
    Int J Mol Sci. 2026;27:3591.
    PubMed         Abstract available
    
    

    
    Int J Urol

38. LONGONI M, Marmiroli A, Falkenbach F, Le QC, et al
    Extent of Pelvic Lymph Node Dissection at Partial Cystectomy: Effect on Cancer-Specific Mortality.
    Int J Urol. 2026;33:e70483.
    PubMed         Abstract available
    
    
39. KAWAHARA T, Nagumo Y, Tanuma K, Hamada K, et al
    Impact of European Association of Urology Combination and Platinum Eligibility on Real-World Treatment Sequences and Survival in Japanese Patients With Metastatic Urothelial Carcinoma.
    Int J Urol. 2026;33:e70403.
    PubMed         Abstract available
    
    
40. LEMES DE, Santos AAS, de Oliveira JL, Roman-Ramos H, et al
    Stage-Dependent Changes in Kynurenine Pathway Enzyme Expression Suggest Immune-Related Involvement in Bladder Cancer Progression.
    Int J Urol. 2026;33:e70491.
    PubMed         Abstract available
    
    

    
    Interdiscip Cardiovasc Thorac Surg

41. LI X, Liao L
    Corynebacterium striatum Infection in Incision and Thoracic Cavity with Concurrent CRKP Colonization Following Lung and Bladder Tumor Resection.
    Interdiscip Cardiovasc Thorac Surg. 2026;41:ivag121.
    PubMed         Abstract available
    
    

    
    J Am Chem Soc

42. WEI Y, Yu Z, Wu S, Li J, et al
    In Vivo Metabolic Engineering of Bladder Cancer-Derived Extracellular Vesicles for Noninvasive Cancer Detection.
    J Am Chem Soc. 2026 May 6. doi: 10.1021/jacs.6c03124.
    PubMed         Abstract available
    
    

    
    J Clin Invest

43. BROWN RJ, Khan MT, Houston AJ, Niu H, et al
    Divergent Macrophage-Regulated T cell States Determine Response to Bacillus Calmette-Guerin vaccine in High-Risk Bladder Cancer.
    J Clin Invest. 2026 Apr 21:e200442. doi: 10.1172/JCI200442.
    PubMed         Abstract available
    
    

    
    J Clin Med

44. GOLOMB D, Simard S, Eisner A, Avda Y, et al
    The Burden of Worry: Fear of Cancer Recurrence Across Bladder Cancer Survivorship Phases-A Cross-Sectional Analysis.
    J Clin Med. 2026;15:3116.
    PubMed         Abstract available
    
    

    
    J Extracell Biol

45. GREENBERG ZF, Hutchinson T, Kahn J, Graim KS, et al
    Urinary Extracellular Vesicles for High-Precision Bladder Cancer Subtyping and Prognosis.
    J Extracell Biol. 2026;5:e70141.
    PubMed         Abstract available
    
    

    
    J Forensic Sci

46. BENEDETTI B, Foschi N, Pesaresi C, Tartaglione T, et al
    Post-mortem CT detection of fatal air embolism after aerosolized fibrin glue for bladder bleeding.
    J Forensic Sci. 2026;71:1507-1512.
    PubMed         Abstract available
    
    

    
    Mater Today Bio

47. WANG P, Ye F, Wang H, Liu J, et al
    Nano-bionic bacteria armed adoptive macrophage therapy against bladder cancer.
    Mater Today Bio. 2026;38:103130.
    PubMed         Abstract available
    
    

    
    Medicina (Kaunas)

48. FALINSKA H, Witkowska-Patena E, Krzyzanowska K, Dziuk M, et al
    Positron Emission Tomography/Computed Tomography in Bladder Cancer: The Role of [(18)F]FDG and Non-FDG Radiotracers.
    Medicina (Kaunas). 2026;62:703.
    PubMed         Abstract available
    
    

    
    Medicine (Baltimore)

49. WU J, Wang Y, Zhao Y, Zheng D, et al
    An unusual cause of a vesical mass: Small bowel diverticulum presenting with a bladder fistula: A case report and review of the literature.
    Medicine (Baltimore). 2026;105:e48536.
    PubMed         Abstract available
    
    

    
    Mol Oncol

50. NYKEL A, Kubiak I, Rutkowska L, Kasprzyk Z, et al
    Clinical performance of the urine-based TERT promoter AbsoluteQ Digital PCR for non-invasive detection of bladder cancer.
    Mol Oncol. 2026 May 5. doi: 10.1002/1878-0261.70262.
    PubMed         Abstract available
    
    

    
    Nano Lett

51. FICHNA K, Crespo-Cuadrado M, Konuparamban A, Di Carlo V, et al
    Nanomotor-Assisted Intravesical Chemotherapy for Bladder Tumor Reduction and Suppression of Early Tumor Regrowth.
    Nano Lett. 2026;26:5618-5627.
    PubMed         Abstract available
    
    

    
    Oncol Lett

52. HUANG T, Xu J, He Y, Shen Y, et al
    Fever and leukemoid reaction in bladder cancer: A case report.
    Oncol Lett. 2026;31:249.
    PubMed         Abstract available
    
    

    
    Pathol Res Pract

53. ZHENG Q, Zhao T, Liao E, Cao Z, et al
    PTEN-low associated mismatch repair deficiency and nuclear PD-L1 expression in basal-type bladder cancer.
    Pathol Res Pract. 2026;283:156509.
    PubMed         Abstract available
    
    

    
    Pharmaceuticals (Basel)

54. ZHAI Z, Wu F, Sheng G, Jia B, et al
    Identification and Functional Analysis of Targets of Dehydrodiisoeugenol in Bladder Cancer Based on Chemoproteomics-Based Profiling.
    Pharmaceuticals (Basel). 2026;19:651.
    PubMed         Abstract available
    
    

    
    Pharmacol Res Perspect

55. O'CALLAGHAN LA, Powell K, Chess-Williams R, McDermott C, et al
    The Antipsychotic Aripiprazole Induces Cytotoxicity in Bladder Cancer Cells While Preserving Urothelial and Bladder Function.
    Pharmacol Res Perspect. 2026;14:e70260.
    PubMed         Abstract available
    
    

    
    Photodiagnosis Photodyn Ther

56. AKIYAMA T, Fukuhara H, Hagiwara Y, Fukata S, et al
    Cost-effectiveness analysis of transurethral resection of bladder tumor with photodynamic diagnosis with 5-aminolevulinic acid hydrochloride for non-muscle invasive bladder cancer.
    Photodiagnosis Photodyn Ther. 2026 Apr 30:105495.
    PubMed         Abstract available
    
    

    
    PLoS One

57. YANG Z, Ma J, Qiang Z, Xie W, et al
    A new target: AlkBH2 promotes bladder cancer by upregulation of inflammation.
    PLoS One. 2026;21:e0348059.
    PubMed         Abstract available
    
    
58. WANG H, Liu H, Sun F, Wu J, et al
    Integrating multi-omics and machine learning to decipher the molecular pathways of bisphenol a-associated lactylation-related genes driving bladder cancer.
    PLoS One. 2026;21:e0347134.
    PubMed         Abstract available
    
    

    
    Rev Med Inst Mex Seguro Soc

59. DIAZ-FUENTES H, Zapot-Martinez JC, Cabrera-Mora NA, Ramos-Arceo E, et al
    [Solitary fibrous tumor of the prostate mimicking a tumor of the vesicoprostatic junction. Case report].
    Rev Med Inst Mex Seguro Soc. 2026;64:e6779.
    PubMed         Abstract available
    
    

    
    Sci Rep

60. KHATRI C, Das PK, Rattan R, Patowary J, et al
    Doublet versus triplet therapy in Indian patients with locally advanced & metastatic gall bladder cancer: a randomised trial.
    Sci Rep. 2026 May 2. doi: 10.1038/s41598-026-36231.
    PubMed         Abstract available
    
    

    
    Support Care Cancer

61. QIU Z, Xia X, Li X
    Comment on "sexual distress in patients after radical cystectomy for bladder cancer: a qualitative study".
    Support Care Cancer. 2026;34:491.
    PubMed        
    
    

    
    Surg Pathol Clin

62. CIMADAMORE A, Lopez-Beltran A, Montironi R, Cheng L, et al
    Molecular Pathology of Genitourinary Tumors: Diagnostic, Prognostic, and Therapeutic Implications.
    Surg Pathol Clin. 2026;19:309-321.
    PubMed         Abstract available
    
    

    
    Ulus Travma Acil Cerrahi Derg

63. SANDIKCI F, Aydin MY, Dogan AE, Yavuz A, et al
    Postoperative ileus as a surgical challenge: comparative outcomes of end-to-end and side-to-side ileal anastomosis in radical cystectomy.
    Ulus Travma Acil Cerrahi Derg. 2026;32:544-551.
    PubMed         Abstract available
    
    

    
    Urol Oncol

64. ARTILES MEDINA A, Subiela JD, Muriel Garcia A, Dominguez Gutierrez A, et al
    A systematic review and meta-analysis of clinicopathologic factors associated with adverse oncologic outcomes in bladder cancer patients undergoing radical cystectomy: Evidence from multivariable survival prediction models.
    Urol Oncol. 2026 May 4:S1078-1439(26)00113-4. doi: 10.1016/j.urolonc.2026.
    PubMed         Abstract available
    
    

    
    Urol Res Pract

65. MITTAL A, Malhotra K, Panwar V, Kishore S, et al
    Targeting Human Epidermal Growth Factor Receptor 2 in Bladder Cancer: Evaluating Its Role as a More Robust Clinicopathological Biomarker Compared to Programmed Death Ligand 1 Expression.
    Urol Res Pract. 2026;52:1-6.
    PubMed         Abstract available
    
    

    
    Vet Surg

66. GRIFFIN MA, Folk C, Buote NJ
    Laparoscopic stapled partial cystectomy with intraoperative cystourethroscopy for urothelial carcinoma in two dogs.
    Vet Surg. 2026;55:856-863.
    PubMed         Abstract available
    
    

    
    World J Urol

67. SENER TE, de Oliveira TR, Demirkiran ED, Perri D, et al
    Face and content validation of TURP and TURB simulation models: an EAU European School of Urology (ESU) Lower Urinary Tract Endoscopy Working Group Study.
    World J Urol. 2026;44:339.
    PubMed         Abstract available
    
    

    
    Zhonghua Zhong Liu Za Zhi

68. 
    [Expert consensus on intravesical therapy for non-muscle invasive bladder cancer (2025 edition)].
    Zhonghua Zhong Liu Za Zhi. 2026;48:462-475.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum